Cronos (CRON) Income from Non-Controlling Interests (2019 - 2026)
Cronos (CRON) posted quarterly Income from Non-Controlling Interests of $1.1 million for Q1 2026, down 31.92% year-over-year from $1.6 million in Q1 2025, and up 3105.88% quarter-over-quarter from $34000.0 in Q4 2025.
Cronos (CRON) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
Cronos' Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests fell 31.92% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.7 million (up 665.58% YoY), while the FY2025 annual figure was $6.5 million, up 716.07% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $1.1 million, up from $34000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $2.4 million in Q3 2025, with the low at -$714000.0 in Q4 2024.
- The 5-year median for Income from Non-Controlling Interests is -$8000.0 (2023), against an average of $298117.6.
- The sharpest annual moves came in 2024 and 2025: Income from Non-Controlling Interests plunged 1562.5% in 2024, then surged 61550.0% in 2025.
- Cronos' Income from Non-Controlling Interests stood at -$16000.0 in 2022, then plunged by 1381.25% to -$237000.0 in 2023, then slumped by 201.27% to -$714000.0 in 2024, then surged by 104.76% to $34000.0 in 2025, then surged by 3105.88% to $1.1 million in 2026.
- Business Quant data shows CRON's Income from Non-Controlling Interests at $1.1 million in Q1 2026, $34000.0 in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 3.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.58 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | -714,000.00 |
| Sep 30, 2024 | -269,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -133,000.00 |
| Dec 31, 2023 | -237,000.00 |
| Sep 30, 2023 | -41,000.00 |
| Jun 30, 2023 | -137,000.00 |
| Mar 31, 2023 | -8,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | 201,000.00 |
| Jun 30, 2022 | 122,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | -265,000.00 |